Surrogate Endpoints in Clinical Trials

This publication has 10 references indexed in Scilit:

• Surrogate markers in aids and cancer trials
  Statistics in Medicine, 1994
• Surrogate and auxiliary endpoints in clinical trials, with potential applications in cancer and aids research
  Statistics in Medicine, 1994
• Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection
  The Lancet, 1994
• A Comparative Trial of Didanosine or Zalcitabine after Treatment with Zidovudine in Patients with Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1994
• Using surrogate failure time data to increase cost effectiveness in clinical trials
  Biometrika, 1993
• Preliminary analysis of the Concorde trial
  The Lancet, 1993
• Evaluating Therapeutic Interventions: Some Issues and Experiences
  Statistical Science, 1992
• A Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous Disease
  New England Journal of Medicine, 1991
• Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial Infarction
  New England Journal of Medicine, 1989
• Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: The CAPS
  The American Journal of Cardiology, 1988